Evidence map›Paper›PMID 27460883›Full record

ArticleScientific reports2016

Liposomal prednisolone inhibits vascular inflammation and enhances venous outward remodeling in a murine arteriovenous fistula model.

ChunYu Wong, Taisiya Bezhaeva, Tonia C Rothuizen, Josbert M Metselaar, Margreet R de Vries, Floris P R Verbeek, Alexander L Vahrmeijer, Anouk Wezel, Anton-Jan van Zonneveld, Ton J Rabelink and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. The rodent models of arteriovenous fistula.Frontiers in cardiovascular medicine · 2024
    Review
  5. Article
  6. Systemic administration of budesonide in pegylated liposomes for improved efficacy in chronic rhinosinusitis.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  7. Review
  8. Article
  9. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Atorvastatin ReducesJournal of the American Society of Nephrology : JASN · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

ChunYu WongDepartment of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Taisiya BezhaevaDepartment of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Tonia C RothuizenDepartment of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Josbert M MetselaarTargeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, The Netherlands.
Margreet R de VriesEinthoven Laboratory for Experimental Vascular Medicine, Leiden Medical Center, Leiden, The Netherlands.
Floris P R VerbeekDepartment of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Alexander L VahrmeijerDepartment of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Anouk WezelDepartment of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Anton-Jan van ZonneveldDepartment of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Ton J RabelinkDepartment of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Paul H A QuaxEinthoven Laboratory for Experimental Vascular Medicine, Leiden Medical Center, Leiden, The Netherlands.
Joris I RotmansDepartment of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Leiden University Medical Center · NLEnceladus Pharmaceuticals (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arteriovenous fistulas (AVF) for hemodialysis access have a 1-year primary patency rate of only 60%, mainly as a result of maturation failure that is caused by insufficient outward remodeling and intimal hyperplasia. The exact pathophysiology remains unknown, but the inflammatory vascular response is thought to play an important role. In the present study we demonstrate that targeted liposomal delivery of prednisolone increases outward remodeling of the AVF in a murine model. Liposomes accumulate in the post-anastomotic area of the venous outflow tract in which the vascular pathology is most prominent in failed AVFs. On a histological level, we observed a reduction of lymphocytes and granulocytes in the vascular wall. In addition, a strong anti-inflammatory effect of liposomal prednisolone on macrophages was demonstrated in vitro. Therefore, treatment with liposomal prednisolone might be a valuable strategy to improve AVF maturation.

Indexed as

AnimalsArteriovenous FistulaCD3 ComplexCells, CulturedCytokinesDisease Models, AnimalInflammationJugular VeinsLeukocyte Common AntigensLiposomesMacrophagesMaleMatrix MetalloproteinasesMice, Inbred C57BLPrednisoloneRNA, MessengerCD3 ComplexCytokinesLeukocyte Common AntigensLiposomesMatrix MetalloproteinasesPrednisoloneRNA, MessengerTissue Inhibitor of Metalloproteinases

Identifiers

PMID27460883
PMCPMC4962038
OpenAlexW2487037319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.